Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
1 other identifier
observational
165
0 countries
N/A
Brief Summary
Epilepsy is the second commonest chronic neurological disorder in developed countries ,comorbidity refers to the co-occurrence of two conditions with greater frequency than found in the general population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 24, 2022
CompletedFirst Posted
Study publicly available on registry
September 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedSeptember 29, 2022
September 1, 2022
8 months
September 24, 2022
September 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Find out comorbidities of epilesy and its treatment
1 year
Eligibility Criteria
Subjects included will be chosen from epilepsy clinic and neurology department at assiut University hospital
You may qualify if:
- Patients with primary epilepsy. Aged above 18 years old.
You may not qualify if:
- patient diagnosed as secondary epilepsy or epilepsy syndromes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
September 24, 2022
First Posted
September 29, 2022
Study Start
September 1, 2022
Primary Completion
May 1, 2023
Study Completion
June 1, 2023
Last Updated
September 29, 2022
Record last verified: 2022-09